SpyGlass Pharma, Inc. Common Stock
NASDAQ:SGPBiotechnology
Healthcare
$29.68 +2.49%
+$0.45 today
- Market cap
- $993.14M
- Beta
- -0.34
- P/E (TTM)
- -14.1
- EPS (TTM)
- -$1.32
52W Low $17.06High $32.44
Volume 0.10M
Average 0.09M
SGP EBITDA Margin
EBITDA as a percentage of revenue.
No reported EBITDA Margin figures are available to summarize.
EBITDA Margin history
Percent of revenue · from the income statement
No EBITDA Margin data reported for this period type.
EBITDA Margin vs competitors
How SGP compares with its peers on the latest reported figures
SGP Competitors Peer median
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Sep 2026 | 25.4% | -0.9 pp | +4.0 pp | |
| LTM Jun 2026 | 13.9% | +4.5 pp | -5.4 pp | |
| LTM Apr 2026 | -1.4% | +10.6 pp | -48.3 pp | |
| LTM Jun 2026 | -23.0% | -12.0 pp | -11.5 pp | |
| LTM Mar 2026 | -33.9% | -19.3 pp | +89.0 pp | |
| LTM Mar 2026 | -39.8% | +16.3 pp | +70.4 pp | |
| LTM Mar 2026 | -527.0% | -231.3 pp | -361.8 pp | |
| LTM Mar 2026 | -3415.1% | -3156.5 pp | -497.7 pp | |
| LTM Mar 2026 | -18676.3% | — | — | |
SGPSpyGlass Pharma, Inc. Common Stock | FY2025 | — | — | — |
| Peer median (excluding SGP) | -33.9% | -6.4 pp | -8.5 pp | |
Competitors are the stored peer set for SGP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
USD
Metric | FY2025 Dec 2025 |
|---|---|
| Revenue | 0 |
| Cost of Revenue | 612K |
| Gross Profit | (612K) |
| Gross Margin | — |
| Research & Development | 28.64M |
| Selling, General & Admin | 12.2M |
| Operating Expenses | 40.84M |
| Depreciation & Amortization | 612K |
| EBITDA | (39.26M) |
| EBITDA Margin | — |
| Operating Income | (41.45M) |
| Operating Margin | — |
| Interest Income | 3.11M |
| Interest Expense | 0 |
| Other Income / Expenses | 1.58M |
| Income Before Tax | (39.87M) |
| Pre-Tax Margin | — |
| Income Tax Expense | 0 |
| Net Income | (39.87M) |
| Net Margin | — |
| EPS (Basic) | (1.19) |
| EPS (Diluted) | (1.19) |
| Weighted Avg Shares | 33.43M |
| Weighted Avg Shares (Diluted) | 33.43M |
SpyGlass Pharma, Inc. Common Stock
NASDAQ:SGP
Intrinsic Alpha fair value
Locked
Current Price
$29.68
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.